Cargando…

Surgical treatment of locally advanced papillary thyroid carcinoma after response to lenvatinib: A case report

INTRODUCTION: Differentiated thyroid carcinomas (DTC) have good prognoses after complete resection. Nevertheless, when DTC is associated with an aerodigestive invasion, curative surgery is difficult to perform. However, there is no established neoadjuvant therapy for advanced DTC. PRESENTATION OF CA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuboi, Mitsuhiro, Takizawa, Hiromitsu, Aoyama, Mariko, Tangoku, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651555/ https://www.ncbi.nlm.nih.gov/pubmed/29055877 http://dx.doi.org/10.1016/j.ijscr.2017.10.010

Ejemplares similares

A case of papillary thyroid carcinoma with renal and pulmonary metastases
por: Aoyama, Mariko, et al.
Publicado: (2022)

Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2019)

A case of thoracoscopic medial basal segmentectomy
por: Kawakita, Naoya, et al.
Publicado: (2019)

Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
por: Takinami, Masaki, et al.
Publicado: (2020)

MON-453 Dramatic Clinical Response to Lenvatinib in a Pediatric Patient with Advanced Metastatic Papillary Thyroid Carcinoma
por: Dujovne, Noelia Vanesa, et al.
Publicado: (2020)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
por: Hyogo, Yasuko, et al.
Publicado: (2018)

Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma
por: Tsuboi, Mitsuhiro, et al.
Publicado: (2019)

Targeting NOX4 disrupts the resistance of papillary thyroid carcinoma to chemotherapeutic drugs and lenvatinib
por: Tang, Ping, et al.
Publicado: (2022)

Brain metastasis from papillary thyroid carcinomas
por: TSUDA, KYOJI, et al.
Publicado: (2013)

Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma
por: Kajiura, Koichiro, et al.
Publicado: (2016)

Lobectomy for lung cancer with a displaced left B(1 + 2) and an anomalous pulmonary vein: a case report
por: Sakamoto, Shinichi, et al.
Publicado: (2021)

Lenvatinib-Associated Cervical Artery Dissections in a Patient with Radioiodine-Refractory Metastatic Papillary Thyroid Carcinoma
por: Groden, Phillip J., et al.
Publicado: (2018)

Lenvatinib in the Treatment of Differentiated Thyroid Cancer and Advanced Renal Cell Carcinoma
por: Patel, Urvi J., et al.
Publicado: (2017)

Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report
por: Tori, Masayuki, et al.
Publicado: (2018)

Surgical resection following therapy with anlotinib in locally advanced papillary thyroid carcinoma: a case description
por: Zhang, Jing, et al.
Publicado: (2023)

GHSR methylation-dependent expression of a variant ligand and receptor of the ghrelin system induces thymoma tumorigenesis
por: Tegshee, Bilguun, et al.
Publicado: (2021)

GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors
por: Soejima, Shiho, et al.
Publicado: (2021)

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
por: Ikeda, Kenji, et al.
Publicado: (2016)

Successful Treatment by Surgery and Lenvatinib of a Patient with Adrenal Metastasis of Papillary Thyroid Cancer
por: Nakamura, Hajime, et al.
Publicado: (2020)

Bronchioalveolar stem cells derived from mouse-induced pluripotent stem cells promote airway epithelium regeneration
por: Kawakita, Naoya, et al.
Publicado: (2020)

Optimal use of lenvatinib in the treatment of advanced thyroid cancer
por: Takahashi, Shunji, et al.
Publicado: (2017)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Long-term management of recurrent papillary thyroid carcinoma treated with lenvatinib for over 5 years: a case report
por: Imai, Tsuneo, et al.
Publicado: (2022)

Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report
por: Buenaventura, Daisy Carolina, et al.
Publicado: (2023)

Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma
por: Roque, João, et al.
Publicado: (2023)

Diagnosis of visceral pleural invasion using confocal laser endomicroscopy during lung cancer surgery
por: Sawada, Toru, et al.
Publicado: (2021)

Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses
por: Tamai, Toshiyuki, et al.
Publicado: (2017)

Long-term efficacy and safety of fourth-line multikinase inhibitor treatment with lenvatinib in a young papillary thyroid carcinoma patient
por: Morelli, S., et al.
Publicado: (2017)

Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report
por: Toda, Soji, et al.
Publicado: (2023)

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
por: Balmelli, Catharina, et al.
Publicado: (2018)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Surgical management for follicular variant of papillary thyroid carcinoma
por: Tang, Jianing, et al.
Publicado: (2017)

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018)

Lenvatinib-Induced Destructive Thyroiditis in a Patient With Hepatocellular Carcinoma
por: Pandya, Anjani, et al.
Publicado: (2021)

Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
por: Tateai, Yoshikazu, et al.
Publicado: (2023)

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
por: Uchida‐Kobayashi, Sawako, et al.
Publicado: (2022)

Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
por: Yamazaki, Haruhiko, et al.
Publicado: (2023)

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
por: Suyama, Koichi, et al.
Publicado: (2017)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mgoem597mjopva2pmub4q3iq1e